E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/10/2015 in the Prospect News High Yield Daily and Prospect News Liability Management Daily.

Pharmaq exercises call on senior secured floating-rate bonds due 2019

By Tali Rackner

Norfolk, Va., Nov. 10 – Pharmaq Holding AS plans to exercise the call option on its senior secured callable floating-rate bonds due 2019, according to a notice from bond trustee Nordic Trustee ASA.

The bonds will be redeemed at 104.245 plus accrued interest on Nov. 16.

On Nov. 3, the company said it expected to redeem the bonds as soon as possible after Salar TopCo AS reached an agreement to sell all of the outstanding shares of Pharmaq to Zoetis Inc.

Based in Norway, Pharmaq is a maker of vaccines and health products for aquaculture.

Zoetis is an animal health subsidiary of Pfizer Inc., based in New York City.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.